Stockguru.com: While Asia Global Holdings Corporation Announce Success, Others Announce New Technology, Close Acquisition, Announce Update, and Announce Presentation
Monday February 12, 2007 04:30:10 EST
Dallas, Texas, Feb 12, 2007 (M2 PRESSWIRE via COMTEX News Network) --
StockGuru Pre-Market Updates for Monday include Seamless Wi-Fi, Inc. (OTCBB SLWF), Advanced Plant Pharmaceuticals, Inc. (OTCBB APPI), Paradigm Medical Industries, Inc. (OTCBB PMED), Palomar Enterprises, Inc. (OTCBB PLMA), Stem Cell Innovations, Inc. (OTCBB SCLL), and Asia Global Holdings Corporation (OTCBB AAGH). StockGuru Pre-Market Updates feature companies with significant moves in either volume or price in the past two trading sessions. In our update we analyze recent news about the companies featured and detail the movement in the stock.
If you would like to feature your publicly traded company in our alerts or on StockGuru.com, email feature@stockguru.com or call (469)252-3031.
Asia Global Holdings Corporation (OTCBB AAGH) Friday\'s market went down 14.06% to $0.0550 per share, with a total of 7,568,476 shares traded. The company is very pleased to announce the success of the ceremony held January 30 in Guangzhou China where over 200 attendees witnessed the contract signing between China Media Power (CMP), a 60% owned subsidiary of Asia Global Holdings Corp, and Celador International Limited, now part of 2waytraffic, to solidify a licensing agreement wherein CMP will produce a minimum of 104 episodes of "Who Wants to Be A Millionaire?" for broadcast nationwide in China beginning in May 2007. Launching "Who Wants To Be A Millionaire?" the global quiz phenomenon in China the worlds most explosive growth market is perfectly in line with CMP parent Asia Global Holdings\' strategy of developing projects with proven potential and management in China.
Asia Global Holdings Corporation has a strong focus on building business in China and other emerging regions and markets in Asia and Worldwide. The company\'s present subsidiaries participate in media & advertising, marketing services and TV entertainment. The Company has offices in the US, Hong Kong and China.
For a quote and the latest news on this company, please visit: www.stockguru.com/profiles/AAGH.php .
Stem Cell Innovations, Inc. (OTCBB SCLL) Friday\'s market went down 16.13% to $0.0520 per share, with a total of 8,574,082 shares traded. The company announced that the Company has submitted its ACTIVTox in vitro toxicology suite to ECVAM to seek validation as an alternative to animal testing in the European Union. Toxicity testing in the pharmaceutical and chemical industries is often performed in rodents. The use of ACTIVTox would reduce the need for animals in clinical testing, saving pharmaceutical companies time and money. ACTIVTox, SCI\'s proprietary highly characterized human liver cell system, is currently being used to accurately predict the response of the liver to a new drug compound. Chemists can then eliminate potential toxicity before entering clinical trials. ACTIVTox is reproducible, relevant to the human and compatible with modern high throughput drug discovery. In addition, ACTIVTox has broad application and can be used to examine toxicity in chemicals, nutraceuticals and cosmetics.
Stem Cell Innovations, Inc., a cell biology company, engages in the sale and marketing of human liver cell line products for use in drug discovery and toxicology testing in the United States. Its products include ACTIVTox, which measures various aspects of liver toxicity and provides a platform for drug discovery; and PREDICTIVTox, a database of information from compounds. The company also develops additional cell lines derived from pluripotent cells and incorporates such cell lines and related databases into the ACTIVTox and PREDICTIVTox product offerings. In addition, it develops technology to develop other products, such as production of antibodies and the treatment of various diseases in vivo cellular replacement therapy, or in ex vivo applications, such as liver assist devices. Further, the company offers contract research and testing, and consulting services. It serves pharmaceutical, dietary supplement, nutraceutical, and chemical industries. Stem Cell Innovations, formerly known as Interferon Sciences, Inc., was incorporated in 1980 and is based in Scotch Plains, New Jersey.
For a quote and the latest news on this company, please visit: www.stockguru.com/profiles/SCLL.php .
Palomar Enterprises, Inc. (OTCBB PLMA) Friday\'s market went up 8.33% to $0.0130 per share, with a total of 9,425,164 shares traded. The company, was featured in a live interview on Market News First with Rich Hancock and Bob Leonard on Jan. 31, 2007. Learn more about the Company, fiscal 2007 projections and its place in the real estate brokerage industry by visiting www.mn1.com and clicking on the Downloads and Podcast icon.
Palomar Enterprises, Inc. engages in buying, renovating, and selling residential real estate properties. It also provides property development services. It operates in two divisions, Financial Services and Corporate Finance. The Financial Services division focuses on mortgage and home loan origination, real state sales and client services, and property acquisition and development. The Corporate Finance division focuses on developing and/or acquiring cash flow positive businesses, as well as acquiring the real property and assets. The company was founded in 1999 and is based in Carson City, Nevada.